Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine

Asian Pacific Journal of Allergy and Immunology

Volumn 25, Issue 4, 2007, Pages 233-242

  Channarong, Sunee ^a   Mitrevej, Ampol ^a   Sinchaipanid, Nuttanan ^a   Usuwantim, Kanchana ^b   Kulkeaw, Kasem ^b   Chaicumpa, Wanpen ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS HEPATITIS B SURFACE ANTIGEN VACCINE; DNA VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN INTERLEUKIN 18 FUSION PROTEIN; INTERLEUKIN 18; PLASMID DNA; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG SCREENING; FEMALE; GENE CONSTRUCT; HEPATITIS B; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; MOLECULAR CLONING; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, VIRAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERLEUKIN-18; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; VACCINES, DNA;

EID: 40749141637     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Heather LD. DNA-based vaccination against hepatitis B virus. Adv Drug Del Rev 1996; 21: 33-47.
2. Tamera MP, Michael DE, Dennis M, et al. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanograin quantities of DNA. Vaccine 1995; 13: 1427-30.
3. Montgomery DL, Ulmer JB, Donnelly JJ, Liu M. DNA vaccine. Pharmacol Ther 1997; 74(2): 195-205.
4. Prange R, Werr M. DNA-mediated immunization to hepatitis B virus envelope proteins: pre S antigen secretion enhances the humoral response. Vaccine 1999; 17: 617-23.
5. Davis HL. DNA-based vaccination against hepatitis B virus. Adv Drug Del Rev 1996; 21: 33-47.
6. Zhao Y, Peng B, Deng H, et al. Anti-HBV immune responses in rhesus macaques elicited by electroporation mediated DNA vaccination. Vaccine 2006; 24: 897-903.
7. Mancini-Bourgine M, Fontaine H, Brichot C, et al. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine 2006; 24: 4482-9.
8. Tacket CO, Roy MJ, Widera G, et al. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 1999; 17: 2826-9.
9. Xu H, Xu W, Chu Y, et al. Single B or T-cell epitope-based DNA vaccine using modified vector induced specific immune response against hepadnavirus. Immunol Letters 2005; 99(2): 186-92.
10. Egan MA, Israel ZR. The use of cytokines and chemokines as genetic adjuvants for plasmid DNA vaccines. Clin Appl Immunol Rev 2002; 2: 255-87.
11. Scheerlinck JY. Genetic adjuvants for DNA. vaccines. Vaccine 2001; 19: 2647-56.
12. Heath AW, Playfair JHL. Cytokines; as immunological adjuvants. Vaccine 1992; 10: 427-34.
13. http://microvet.arizona.edu/Courses/MIC419/Tutorials/cytokines.html [Accessed Oct 20, 2006].
14. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378 (6552): 88-91.
15. Dinarello CA. Interleukin-18. Methods 1999; 19: 121-32.
16. Marshall DJ, Rudnick KA, McCarthy SG, et al. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine. Vaccine 2006; 24: 244-53.
17. http://www-personal.umich-edu/~ino/blast.html.
18. Davis HL, Michel ML, Whalen RG. DNA-based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum Mol Genetics 1993; 2: 1847-51.
19. Ulmer JB, Dewitt CM, Chatain M, et al. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine 2000; 18: 18-28.
20. Wang S, Liu X, Fisher K, et al. Enhanced type I immune to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate. Vaccine 2000; 18: 1227-35.
21. http://www.ncbi.nlm.nih.gov/enterz/ query.fcgi?cmd=Retrieve&db=Protein&list_uids--87299475&dopt- GenPept [Accessed Oct 20, 2006).
22. http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=DQ-299409.1 [Accessed Nov 4, 2006].
23. Lena P, Villinger F, Giavedoni L, et al. Co-immunization of rhesus macaques with plasmid vectors expressing IFN-γ, GM-CSF, and SIV antigens enhances anti-viral humoral immunity but does not affect viremia after challenge with highly pathogenic virus. Vaccine 2002; 209 (Suppl.4): A69-A79.
24. Kim JJ, Yang J, Manson KH, Weiner DB. Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-γ, or IL-4 gene adjuvants. Vaccine 2001; 19: 2496-505.
25. Yen H, Scheerlinck JY. Co-delivery of plasmid-encoded cytokines modulates the iminune response to a DNA vaccine delivered by in vivo electroporation. Vaccine 2007; 25: 2575-82.
26. Dinarello CA. IL-18: A Th1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103: 11-24.
27. Okamura, H, Kashiwamura S, Tsutsuit H, et al. Regulation of interferon-γ production by IL-12 and IL-18. Curr Opin Immunol 1998; 10: 259-64.